Back to Annual Meeting Page
133rd Annual Meeting & Exposition
December 10-14, 2005
Philadelphia, PA
|
Back to Annual Meeting Page
|
133rd Annual Meeting & Exposition December 10-14, 2005 Philadelphia, PA |
|
|
4099.0: Tuesday, December 13, 2005: 12:30 PM-2:00 PM | |||
Oral | |||
| |||
| Performance measures offer the potential to be powerful tools in states’ efforts to improve the quality of care for individuals with substance use disorders. The goal of any performance measurement plan includes the generation of data that can be used for quality improvement of the services offered, monitoring outcomes, and providing accountability. This session provides overviews of performance measurement for substance abuse treatment; specific measures developed by the Washington Circle and adopted by the National Committee for Quality Assurance in 2004; the National Outcome Measure system being initiated by SAMHSA; information to help States develop, initiate or enhance a performance management process; and a description of Oklahoma’s use of data to calculate performance measures and apply them for quality monitoring and improvement. | |||
| Learning Objectives: See individual abstracts | |||
| Gabrielle Denmead | |||
| Constance M. Horgan, ScD | |||
| Substance abuse performance measurement: Overview of the state of the art Constance M. Horgan, ScD, Deborah W. Garnick, ScD | |||
| Performance measures for substance abuse: Issues in public sector applications Deborah W. Garnick, ScD, Mady Chalk, PhD, Constance M. Horgan, ScD, Margaret T. Lee, PhD, Frank McCorry, PhD, Sarah Wattenberg, MA | |||
| National outcome measures: SAMHSA’s path to performance management Javaid Kaiser, PhD | |||
Performance management: Improving State systems through information-based decisionmaking ![[ Recorded presentation ]](/static/img/filetypes/16x16/wrf.gif){kind=small} Mary Brolin, PhD, Carol A. Seaver, MA, Dennis Nalty, PhD | |||
| State agency measurement system development: Oklahoma's experience Steve Davis, PhD, Tracy Leeper, MA, Mark Reynolds, EdD | |||
| See individual abstracts for presenting author's disclosure statement and author's information. | |||
| Organized by: | Alcohol, Tobacco, and Other Drugs | ||
| Endorsed by: | Public Health Nursing | ||
| CE Credits: | CME, Health Education (CHES), Nursing | ||
The 133rd Annual Meeting & Exposition (December 10-14, 2005) of APHA